SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-003598
Filing Date
2017-05-05
Accepted
2017-05-05 07:47:25
Documents
58
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20170331x10q.htm 10-Q 1680003
2 EX-10.1 ocul-20170331ex1010a5c41.htm EX-10.1 965290
3 EX-31.1 ocul-20170331ex311b831d6.htm EX-31.1 14555
4 EX-31.2 ocul-20170331ex3123fb329.htm EX-31.2 10191
5 EX-32.1 ocul-20170331ex321075153.htm EX-32.1 7112
6 EX-32.2 ocul-20170331ex322cec6fc.htm EX-32.2 6748
  Complete submission text file 0001558370-17-003598.txt   5729810

Data Files

Seq Description Document Type Size
7 EX-101.INS ocul-20170331.xml EX-101.INS 781983
8 EX-101.SCH ocul-20170331.xsd EX-101.SCH 37494
9 EX-101.CAL ocul-20170331_cal.xml EX-101.CAL 47226
10 EX-101.DEF ocul-20170331_def.xml EX-101.DEF 124753
11 EX-101.LAB ocul-20170331_lab.xml EX-101.LAB 295832
12 EX-101.PRE ocul-20170331_pre.xml EX-101.PRE 239666
Mailing Address 34 CROSBY DRIVE SUITE 105 BEDFORD MA 01730
Business Address 34 CROSBY DRIVE SUITE 105 BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 17816101
SIC: 2834 Pharmaceutical Preparations